Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F G Barr

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
American Journal of Clinical Pathology|July 9, 1999
Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcomaM van de Rijn, F G Barr, M H Collins, et al.
Nature Genetics|February 1, 1993
Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcomaF G Barr, N Galili, J Holick, et al.
Cancer Research|August 29, 1998
Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcomaJ P Ginsberg, R J Davis, J L Bennicelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcomaK M Kelly, R B Womer, P H Sorensen, et al.
Cancer Research|June 1, 1994
Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcomaR J Davis, C M D'Cruz, M A Lovell, et al.
Oncogene|July 6, 1995
Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domainsJ L Bennicelli, W J Fredericks, R B Wilson, et al.
The American Journal of Surgical Pathology|January 15, 1999
Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic featuresM van de Rijn, F G Barr, Q B Xiong, et al.
Molecular and Cellular Biology|March 1, 1995
The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3W J Fredericks, N Galili, S Mukhopadhyay, et al.
Cancer Research|December 20, 1999
Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell linesF G Barr, J C Fitzgerald, J P Ginsberg, et al.
Human Molecular Genetics|January 1, 1996
In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcomaF G Barr, L E Nauta, R J Davis, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
American Journal of Clinical Pathology|July 9, 1999
Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcomaM van de Rijn, F G Barr, M H Collins, et al.
Nature Genetics|February 1, 1993
Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcomaF G Barr, N Galili, J Holick, et al.
Cancer Research|August 29, 1998
Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcomaJ P Ginsberg, R J Davis, J L Bennicelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcomaK M Kelly, R B Womer, P H Sorensen, et al.
Cancer Research|June 1, 1994
Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcomaR J Davis, C M D'Cruz, M A Lovell, et al.
Oncogene|July 6, 1995
Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domainsJ L Bennicelli, W J Fredericks, R B Wilson, et al.
The American Journal of Surgical Pathology|January 15, 1999
Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic featuresM van de Rijn, F G Barr, Q B Xiong, et al.
Molecular and Cellular Biology|March 1, 1995
The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3W J Fredericks, N Galili, S Mukhopadhyay, et al.
Cancer Research|December 20, 1999
Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell linesF G Barr, J C Fitzgerald, J P Ginsberg, et al.
Human Molecular Genetics|January 1, 1996
In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcomaF G Barr, L E Nauta, R J Davis, et al.
Pageof 7